Entero Healthcare [ENTERO] vs Royal Sense [ROYAL] Detailed Stock Comparison

Entero Healthcare Solutions

NSE

Royal Sense Ltd.

BSE

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Entero Healthcare Solutions wins in 7 metrics, Royal Sense Ltd. wins in 11 metrics, with 0 ties. Royal Sense Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Entero Healthcare Solutions	Royal Sense Ltd.	Better
P/E Ratio (TTM)	48.93	14.61	Royal Sense Ltd.
Price-to-Book Ratio	3.11	2.60	Royal Sense Ltd.
Debt-to-Equity Ratio	24.63	19.41	Royal Sense Ltd.
PEG Ratio	5.72	N/A	N/A
EV/EBITDA	28.71	8.50	Royal Sense Ltd.
Profit Margin (TTM)	1.87%	9.63%	Royal Sense Ltd.
Operating Margin (TTM)	3.40%	13.28%	Royal Sense Ltd.
EBITDA Margin (TTM)	3.40%	13.28%	Royal Sense Ltd.
Return on Equity	5.36%	28.62%	Royal Sense Ltd.
Return on Assets (TTM)	3.51%	18.97%	Royal Sense Ltd.
Free Cash Flow (TTM)	$-881.80M	$-4.08M	Royal Sense Ltd.
1-Year Return	-4.75%	-59.36%	Entero Healthcare Solutions
Price-to-Sales Ratio (TTM)	0.91	1.11	Entero Healthcare Solutions
Enterprise Value	$58.10B	$977.38M	Entero Healthcare Solutions
EV/Revenue Ratio	0.97	1.18	Entero Healthcare Solutions
Gross Profit Margin (TTM)	10.11%	15.60%	Royal Sense Ltd.
Revenue per Share (TTM)	$1,383	$161	Entero Healthcare Solutions
Earnings per Share (Diluted)	$25.83	$11.83	Entero Healthcare Solutions
Beta (Stock Volatility)	-0.79	0.59	Entero Healthcare Solutions

Entero Healthcare Solutions vs Royal Sense Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Entero Healthcare Solutions	-1.26%	0.29%	-5.86%	12.11%	12.06%	-0.64%
Royal Sense Ltd.	5.88%	0.93%	-22.86%	-30.37%	-49.77%	-40.28%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Entero Healthcare Solutions	-4.75%	-1.12%	-1.12%	-1.12%	-1.12%	-1.12%
Royal Sense Ltd.	-59.36%	-8.50%	-8.50%	-8.50%	-8.50%	-8.50%

Performance & Financial Health Analysis: Entero Healthcare Solutions vs Royal Sense Ltd.

Metric	ENTERO	ROYAL
Market Information
Market Cap i	₹54.69B	₹924.51M
Market Cap Category	Mid cap	Small cap
10 Day Avg. Volume i	76,067	14,200
90 Day Avg. Volume i	89,093	8,000
Last Close	₹1,122.40	₹108.00
52 Week Range	₹944.00 - ₹1,390.00	₹102.00 - ₹309.75
% from 52W High	-19.25%	-65.13%
All-Time High	₹1,584.25 (Nov 04, 2024)	₹316.05 (Dec 30, 2024)
% from All-Time High	-29.15%	-65.83%
Growth Metrics
Quarterly Revenue Growth	0.26%	2.93%
Quarterly Earnings Growth	0.09%	1.11%
Financial Health
Profit Margin (TTM) i	0.02%	0.10%
Operating Margin (TTM) i	0.03%	0.13%
Return on Equity (TTM) i	0.05%	0.29%
Debt to Equity (MRQ) i	24.63	19.41
Cash & Liquidity
Book Value per Share (MRQ)	₹405.79	₹66.58
Cash per Share (MRQ)	₹37.37	₹1.87
Operating Cash Flow (TTM) i	₹-1,784,990,000	₹-70,281,000
Levered Free Cash Flow (TTM) i	₹948.20M	₹-150,242,752
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Entero Healthcare Solutions vs Royal Sense Ltd.

Metric	ENTERO (Apr 24, 2026)	ROYAL (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i	48.93	14.61
Forward P/E i	28.42	N/A
PEG Ratio i	5.72	N/A
Price to Sales (TTM) i	0.91	1.11
Price to Book (MRQ) i	3.11	2.60
Market Capitalization
Market Capitalization i	₹54.69B	₹924.51M
Enterprise Value i	₹58.10B	₹977.38M
Enterprise Value Metrics
Enterprise to Revenue i	0.97	1.18
Enterprise to EBITDA i	28.71	8.50
Risk & Other Metrics
Beta i	-0.79	0.59
Book Value per Share (MRQ) i	₹405.79	₹66.58

Financial Statements Comparison: Entero Healthcare Solutions vs Royal Sense Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

Metric	ENTERO (2025)	ROYAL (2025)
Revenue/Sales i	50.65B	617.34M
Cost of Goods Sold i	46.09B	495.71M
COGS % of Revenue i	91.0%	80.3%
Gross Profit i	4.56B	121.63M
Gross Margin i	9.0%	19.7%
Research & Development i	N/A	N/A
Operating Income (EBIT) i	1.42B	88.67M
Operating Margin i	2.8%	14.4%
EBITDA i	2.07B	88.97M
EBITDA Margin i	4.1%	14.4%
Pre-Tax Income i	1.39B	87.35M
Pre-Tax Income % of Revenue i	2.7%	14.1%
Income Tax i	313.05M	24.03M
Income Tax % of Revenue i	0.6%	3.9%
Net Income (Profit) i	1.07B	63.31M
Profit Margin i	2.1%	10.3%

Balance Sheet & Liquidity Metrics

Metric	ENTERO (2025)	ROYAL (2025)
Cash & Equivalents i	2.29B	112.47M
Total Current Assets i	20.76B	333.53M
Total Current Assets % of Revenue i	41.0%	54.0%
Total Current Liabilities i	8.45B	76.34M
Total Current Liabilities % of Revenue i	16.7%	12.4%
Long-Term Debt i	670.18M	1.05M
Long-Term Debt % of Revenue i	1.3%	0.2%
Total Shareholders Equity i	17.70B	277.37M
Retained Earnings i	638.28M	79.20M
Retained Earnings % of Revenue i	1.3%	12.8%
Property, Plant & Equipment i	1.64B	0

Cash Flow Statement Comparison

Metric	ENTERO (2025)	ROYAL (2025)
Operating Cash Flow i	-1.78B	5.21M
Operating Cash Flow % of Revenue i	-3.5%	0.8%
Capital Expenditures i	-103.73M	-16.16M
Free Cash Flow i	-881.80M	-4.08M
FCF Margin i	-1.7%	-0.7%
Debt Repayment i	-458.22M	-1.16M
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	ENTERO	ROYAL
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Shares Outstanding i	43.51M	4.90M
Float Shares i	14.37M	1.60M
% Held by Insiders i	65.97%	68.64%
% Held by Institutions i	12.55%	0.00%
% Held by Public i	21.48%	31.36%

Dividend Analysis & Yield Comparison: Entero Healthcare Solutions vs Royal Sense Ltd.

Metric	ENTERO	ROYAL
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Metric	ENTERO (Jun 30, 2025)	ROYAL (Sep 30, 2023)
Revenue/Sales i	14.04B	33.92M
Cost of Goods Sold i	12.64B	28.63M
COGS % of Revenue i	90.1%	84.4%
Gross Profit i	1.40B	5.29M
Gross Margin i	9.9%	15.6%
Research & Development i	N/A	N/A
Operating Income (EBIT) i	412.02M	2.60M
Operating Margin i	2.9%	7.7%
EBITDA i	558.96M	2.69M
EBITDA Margin i	4.0%	7.9%
Pre-Tax Income i	363.63M	2.65M
Pre-Tax Income % of Revenue i	2.6%	7.8%
Income Tax i	61.31M	690,000
Income Tax % of Revenue i	0.4%	2.0%
Net Income (Profit) i	302.32M	1.96M
Profit Margin i	2.2%	5.8%

Entero Healthcare [ENTERO] vs Royal Sense [ROYAL] Detailed Stock Comparison

Entero Healthcare Solutions

Royal Sense Ltd.

TLDR: Quick Comparison Summary

Vital Metrics Comparison

Complete Entero Healthcare Solutions Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

🏥 Which Company is Healthier

📈 Which Has Been Growing Faster

💵 Which Pays You Better

Entero Healthcare Solutions vs Royal Sense Ltd. Stock Performance Analysis

Performance Comparison

Short-term Returns

Long-term Returns

Performance & Financial Health Analysis: Entero Healthcare Solutions vs Royal Sense Ltd.

Valuation & Enterprise Metrics Analysis: Entero Healthcare Solutions vs Royal Sense Ltd.

Financial Statements Comparison: Entero Healthcare Solutions vs Royal Sense Ltd.

Financial Metrics

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

ENTERO (Annual)

ENTERO (Quarterly)

ROYAL (Annual)

ROYAL (Quarterly)

Financial Statements Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Short Interest & Institutional Ownership Analysis

Dividend Analysis & Yield Comparison: Entero Healthcare Solutions vs Royal Sense Ltd.

Metric	ENTERO (Jun 30, 2025)	ROYAL (Sep 30, 2023)
Cash & Equivalents i	2.29B	30.67M
Total Current Assets i	20.76B	223.51M
Total Current Assets % of Revenue i	147.9%	658.8%
Total Current Liabilities i	8.45B	34.38M
Total Current Liabilities % of Revenue i	60.2%	101.3%
Long-Term Debt i	670.18M	N/A
Long-Term Debt % of Revenue i	4.8%	0.0%
Total Shareholders Equity i	17.70B	205.89M
Retained Earnings i	638.28M	N/A
Retained Earnings % of Revenue i	4.5%	0.0%
Property, Plant & Equipment i	1.64B	N/A

Metric	ENTERO (Jun 30, 2025)	ROYAL (Sep 30, 2023)
Operating Cash Flow i	N/A	50.91M
Operating Cash Flow % of Revenue i	0.0%	150.1%
Capital Expenditures i	N/A	233,000
Free Cash Flow i	N/A	26.63M
FCF Margin i	0.0%	78.5%
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Entero Healthcare [ENTERO] vs Royal Sense [ROYAL] Detailed Stock Comparison

Entero Healthcare Solutions

Royal Sense Ltd.

TLDR: Quick Comparison Summary

Vital Metrics Comparison

Complete Entero Healthcare Solutions Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

🏥 Which Company is Healthier

📈 Which Has Been Growing Faster

💵 Which Pays You Better

Entero Healthcare Solutions vs Royal Sense Ltd. Stock Performance Analysis

Performance Comparison

Short-term Returns

Long-term Returns

Performance & Financial Health Analysis: Entero Healthcare Solutions vs Royal Sense Ltd.

Valuation & Enterprise Metrics Analysis: Entero Healthcare Solutions vs Royal Sense Ltd.

Financial Statements Comparison: Entero Healthcare Solutions vs Royal Sense Ltd.

Financial Metrics Quarterly Annual

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

ENTERO (Annual)

ENTERO (Quarterly)

ROYAL (Annual)

ROYAL (Quarterly)

Financial Statements Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Short Interest & Institutional Ownership Analysis

Dividend Analysis & Yield Comparison: Entero Healthcare Solutions vs Royal Sense Ltd.

Financial Metrics